# Gilead Sciences, Inc. (GILD) — Q4-2011 Earnings Results

**Report date:** 2012-02-02 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q4-2011

## Post-Earnings Brief

### Headline

Gilead Sciences Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.97 | N/A | -3.29% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management maintained a neutral tone during the call, focusing on long-term strategies rather than immediate financial performance. There were no significant updates or guidance provided.

**Key quotes:**

> Management did not provide specific insights on revenue performance.

> The company emphasized ongoing strategic initiatives.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Gilead Sciences did not meet earnings expectations, which could raise concerns among investors about its current financial health. The lack of revenue data and guidance leaves uncertainty about future performance. The stock reaction is not available, but the EPS miss may lead to cautious sentiment among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q4-2011_